Thomas Nusbickel, Chief Commercial Officer, Celltrion USA
Advertisement
Articles by Thomas Nusbickel, Chief Commercial Officer, Celltrion USA
Advertisement
Latest Updated Articles
- Beyond Approvals: Establishing a Patient-Centric Approach to Biosimilars
Published: July 5th 2023 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
2025 FDA added indications to dermatologic medications
2
Immune system targets single beta cells before Type 1 diabetes symptoms show
3
Jascayd gets second FDA approval, this time for progressive pulmonary fibrosis
4
What NCCN’s next CMO sees ahead for cancer guidelines, access and innovation
5